Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study
- PMID: 38464725
- PMCID: PMC10921231
- DOI: 10.3389/fphar.2024.1366852
Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study
Abstract
In the past 11 years, there has been a surge in studies exploring the regulatory effect of Traditional Chinese Medicine (TCM) on ferroptosis. However, a significant gap persists in comprehensive scientometric analysis and scientific mapping research, especially in tracking the evolution, primary contributors, and emerging research focal points. This study aims to comprehensively update the advancements in targeting ferroptosis with various TCMs during the previous 11 years. The data, covering the period from 1 January 2012, to 30 November 2023, were retrieved from the Web of Science database. For in-depth scientometric and visualized analyses, a series of advanced analytical instruments were employed. The findings highlight China's predominant role, accounting for 71.99% of total publications and significantly shaping research in this domain. Noteworthy productivity was observed at various institutions, including Guangzhou University of Chinese Medicine, Chengdu University of Traditional Chinese Medicine, and Zhejiang University. Thomas Efferth emerged as the foremost author within this field, while Frontiers in Pharmacology boasted the highest publication count. This study pinpointed hepatocellular carcinoma, chemical and drug-induced liver injury, mitochondrial diseases, acute kidney injury, and liver failure as the most critical disorders addressed in this research realm. The research offers a comprehensive bibliometric evaluation, enhancing our understanding of the present status of TCM therapy in managing ferroptosis-related diseases. Consequently, it aids both seasoned researchers and newcomers by accelerating access to vital information and fostering innovative concept extraction within this specialized field.
Keywords: Traditional Chinese Medicine; bibliometrics; ferroptosis; global scientific frontiers; visualized analysis.
Copyright © 2024 Cao, Wei, Yue, Chen, Liao, Li, Liu, Xiong and Zeng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures










Similar articles
-
Mapping the evolution and research landscape of ferroptosis-targeted nanomedicine: insights from a scientometric analysis.Front Pharmacol. 2024 Sep 25;15:1477938. doi: 10.3389/fphar.2024.1477938. eCollection 2024. Front Pharmacol. 2024. PMID: 39386034 Free PMC article.
-
Uncovering the scientific landscape: A bibliometric and Visualized Analysis of artificial intelligence in Traditional Chinese Medicine.Heliyon. 2024 Sep 10;10(18):e37439. doi: 10.1016/j.heliyon.2024.e37439. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39315188 Free PMC article.
-
Targeting ferroptosis reveals a new strategy for breast cancer treatment: a bibliometric study.Discov Oncol. 2024 Nov 19;15(1):679. doi: 10.1007/s12672-024-01569-x. Discov Oncol. 2024. PMID: 39560863 Free PMC article.
-
Bibliometric and graphical analysis of ferroptosis and aging research: Trends, gaps, and future directions.Pathol Res Pract. 2025 May;269:155949. doi: 10.1016/j.prp.2025.155949. Epub 2025 Mar 28. Pathol Res Pract. 2025. PMID: 40174280 Review.
-
Global research status and trends of interactions between Traditional Chinese medicine and pulmonary fibrosis: A new dawn in treatment.Heliyon. 2024 Jul 14;10(14):e34592. doi: 10.1016/j.heliyon.2024.e34592. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39149021 Free PMC article. Review.
Cited by
-
Gut microbiota and myocardial infarction: A bibliometric analysis from 2004 to 2023.Heliyon. 2024 Aug 30;10(17):e37139. doi: 10.1016/j.heliyon.2024.e37139. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39296144 Free PMC article.
-
Rosiglitazone retards the progression of iron overload-induced osteoarthritis by impeding chondrocyte ferroptosis.iScience. 2024 Jul 31;27(9):110526. doi: 10.1016/j.isci.2024.110526. eCollection 2024 Sep 20. iScience. 2024. PMID: 39224514 Free PMC article.
-
Mapping the evolution and research landscape of ferroptosis-targeted nanomedicine: insights from a scientometric analysis.Front Pharmacol. 2024 Sep 25;15:1477938. doi: 10.3389/fphar.2024.1477938. eCollection 2024. Front Pharmacol. 2024. PMID: 39386034 Free PMC article.
-
Zooming in and Out of Programmed Cell Death in Osteoarthritis: A Scientometric and Visualized Analysis.J Inflamm Res. 2024 Apr 23;17:2479-2498. doi: 10.2147/JIR.S462722. eCollection 2024. J Inflamm Res. 2024. PMID: 38681072 Free PMC article. Review.
-
A bibliometric worldview of breast-conserving surgery for breast cancer from 2013 to 2023.Front Oncol. 2024 Jul 19;14:1405351. doi: 10.3389/fonc.2024.1405351. eCollection 2024. Front Oncol. 2024. PMID: 39099692 Free PMC article.
References
-
- Bhinder B., Gilvary C., Madhukar N. S., Elemento O. (2021). Artificial intelligence in cancer research and precision medicine. Cancer Discov. 11 (4), 900–915. 10.1158/2159-8290.CD-21-0090 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous